Researchers at Georgia Institute of Technology and Emory University Release New Study Findings on Gliomas (Cinnamaldehyde impacts key cellular signaling pathways for induction of programmed cell death in high-grade and low-grade human glioma...).

Researchers from Georgia Institute of Technology and Emory University conducted a study on gliomas, a type of brain tumor that includes high-grade glioblastoma multiforme (GBMs) and low-grade gliomas (LGGs). The study focused on the impact of cinnamaldehyde (CA) on cellular signaling pathways, specifically in inducing programmed cell death in both GBMs and LGGs. The findings suggest that CA could potentially be a therapeutic option with fewer adverse side effects, potentially inhibiting the progression of LGGs to GBMs. For more information, the full study is available in BMC Research Notes. [Extracted from the article]